These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 28821884)

  • 1. The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins.
    Brunner PM; Suárez-Fariñas M; He H; Malik K; Wen HC; Gonzalez J; Chan TC; Estrada Y; Zheng X; Khattri S; Dattola A; Krueger JG; Guttman-Yassky E
    Sci Rep; 2017 Aug; 7(1):8707. PubMed ID: 28821884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature.
    Pavel AB; Zhou L; Diaz A; Ungar B; Dan J; He H; Estrada YD; Xu H; Fernandes M; Renert-Yuval Y; Krueger JG; Guttman-Yassky E
    J Am Acad Dermatol; 2020 Mar; 82(3):690-699. PubMed ID: 31669080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities.
    He H; Del Duca E; Diaz A; Kim HJ; Gay-Mimbrera J; Zhang N; Wu J; Beaziz J; Estrada Y; Krueger JG; Pavel AB; Ruano J; Guttman-Yassky E
    J Allergy Clin Immunol; 2021 Apr; 147(4):1369-1380. PubMed ID: 33011244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cardiovascular and atherosclerosis markers in blood of older patients with atopic dermatitis.
    He H; Li R; Choi S; Zhou L; Pavel A; Estrada YD; Krueger JG; Guttman-Yassky E
    Ann Allergy Asthma Immunol; 2020 Jan; 124(1):70-78. PubMed ID: 31622668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease.
    Brunner PM; He H; Pavel AB; Czarnowicki T; Lefferdink R; Erickson T; Canter T; Puar N; Rangel SM; Malik K; Estrada Y; Krueger JG; Guttman-Yassky E; Paller AS
    J Am Acad Dermatol; 2019 Aug; 81(2):510-519. PubMed ID: 31009665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation.
    Glickman JW; Dubin C; Renert-Yuval Y; Dahabreh D; Kimmel GW; Auyeung K; Estrada YD; Singer G; Krueger JG; Pavel AB; Guttman-Yassky E
    J Am Acad Dermatol; 2021 Feb; 84(2):370-380. PubMed ID: 32376430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers.
    He H; Olesen CM; Pavel AB; Clausen ML; Wu J; Estrada Y; Zhang N; Agner T; Guttman-Yassky E
    Front Immunol; 2020; 11():1768. PubMed ID: 32849633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-onset pediatric atopic dermatitis is T
    Esaki H; Brunner PM; Renert-Yuval Y; Czarnowicki T; Huynh T; Tran G; Lyon S; Rodriguez G; Immaneni S; Johnson DB; Bauer B; Fuentes-Duculan J; Zheng X; Peng X; Estrada YD; Xu H; de Guzman Strong C; Suárez-Fariñas M; Krueger JG; Paller AS; Guttman-Yassky E
    J Allergy Clin Immunol; 2016 Dec; 138(6):1639-1651. PubMed ID: 27671162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing.
    Suárez-Fariñas M; Ungar B; Noda S; Shroff A; Mansouri Y; Fuentes-Duculan J; Czernik A; Zheng X; Estrada YD; Xu H; Peng X; Shemer A; Krueger JG; Lebwohl MG; Guttman-Yassky E
    J Allergy Clin Immunol; 2015 Nov; 136(5):1277-87. PubMed ID: 26316095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis.
    Kagami S; Kakinuma T; Saeki H; Tsunemi Y; Fujita H; Nakamura K; Takekoshi T; Kishimoto M; Mitsui H; Torii H; Komine M; Asahina A; Tamaki K
    Clin Exp Immunol; 2003 Nov; 134(2):309-13. PubMed ID: 14616792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults.
    Renert-Yuval Y; Del Duca E; Pavel AB; Fang M; Lefferdink R; Wu J; Diaz A; Estrada YD; Canter T; Zhang N; Wagner A; Chamlin S; Krueger JG; Guttman-Yassky E; Paller AS
    J Allergy Clin Immunol; 2021 Jul; 148(1):148-163. PubMed ID: 33453290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis.
    Pavel AB; Song T; Kim HJ; Del Duca E; Krueger JG; Dubin C; Peng X; Xu H; Zhang N; Estrada YD; Denis L; Rao N; Gupta S; Zammit DJ; Bissonnette R; Guttman-Yassky E
    J Allergy Clin Immunol; 2019 Oct; 144(4):1011-1024. PubMed ID: 31356921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Immune Development in Infants With Moderate to Severe Atopic Dermatitis.
    Hulshof L; Overbeek SA; Wyllie AL; Chu MLJN; Bogaert D; de Jager W; Knippels LMJ; Sanders EAM; van Aalderen WMC; Garssen J; Van't Land B; Sprikkelman AB;
    Front Immunol; 2018; 9():630. PubMed ID: 29966024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris.
    Kakinuma T; Saeki H; Tsunemi Y; Fujita H; Asano N; Mitsui H; Tada Y; Wakugawa M; Watanabe T; Torii H; Komine M; Asahina A; Nakamura K; Tamaki K
    J Allergy Clin Immunol; 2003 Mar; 111(3):592-7. PubMed ID: 12642842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis.
    Zhou L; Leonard A; Pavel AB; Malik K; Raja A; Glickman J; Estrada YD; Peng X; Del Duca E; Sanz-Cabanillas J; Ruano J; Xu H; Zhang N; Wen HC; Gonzalez J; Garcet S; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2019 Jul; 144(1):144-156. PubMed ID: 30685456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age of onset defines two distinct profiles of atopic dermatitis in adults.
    Facheris P; Da Rosa JC; Pagan AD; Angelov M; Del Duca E; Rabinowitz G; Gómez-Arias PJ; Rothenberg-Lausell C; Estrada YD; Bose S; Chowdhury M; Shemer A; Pavel AB; Guttman-Yassky E
    Allergy; 2023 Aug; 78(8):2202-2214. PubMed ID: 37032461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment.
    Guttman-Yassky E; Krueger JG; Lebwohl MG
    Exp Dermatol; 2018 Apr; 27(4):409-417. PubMed ID: 28266782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization.
    Noda S; Suárez-Fariñas M; Ungar B; Kim SJ; de Guzman Strong C; Xu H; Peng X; Estrada YD; Nakajima S; Honda T; Shin JU; Lee H; Krueger JG; Lee KH; Kabashima K; Guttman-Yassky E
    J Allergy Clin Immunol; 2015 Nov; 136(5):1254-64. PubMed ID: 26428954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis.
    Khattri S; Brunner PM; Garcet S; Finney R; Cohen SR; Oliva M; Dutt R; Fuentes-Duculan J; Zheng X; Li X; Bonifacio KM; Kunjravia N; Coats I; Cueto I; Gilleaudeau P; Sullivan-Whalen M; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
    Exp Dermatol; 2017 Jan; 26(1):28-35. PubMed ID: 27304428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic characterization of atopic dermatitis blood from infancy to adulthood.
    Del Duca E; Renert-Yuval Y; Pavel AB; Mikhaylov D; Wu J; Lefferdink R; Fang M; Sheth A; Blumstein A; Facheris P; Estrada YD; Rangel SM; Krueger JG; Paller AS; Guttman-Yassky E
    J Am Acad Dermatol; 2023 May; 88(5):1083-1093. PubMed ID: 36773824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.